Abstract
The molecular mechanisms by which drugs bind to and regulate G-proteincoupled receptors (GPCR) remains a major unsolved problem for modern molecular biologists, biochemists and structural biologists. Ideally, we would like to ultimately define drug binding at the atomic level. An ideal molecular model would also be able to demonstrate why it is that agonists activate receptors while antagonists, which may or may not bind in overlapping domains, do not activate receptors. A perfect molecular explanation of drug action would elucidate the molecular determinants responsible for cellular regulation processes (e.g. desensitization, internalization and downregulation). At the present time, there are no verifiable models which elucidate these properties for any G-protein-coupled receptor.KeywordsAtypical Antipsychotic DrugD120N MutationLysergic Acid DiethylamideTypical Antipsychotic DrugHelical ArrangementThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.